# Morphine-Sparing Efficacy Of Parecoxib In Pain Treatment After Radical Prostatectomy

> **NCT00346268** · PHASE4 · TERMINATED · sponsor: **Pfizer** · enrollment: 105 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Morphine, Parecoxib
- **DRUG:** Morphine, Placebo

## Key facts

- **NCT ID:** NCT00346268
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-12
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 105 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2011-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00346268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00346268, "Morphine-Sparing Efficacy Of Parecoxib In Pain Treatment After Radical Prostatectomy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00346268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*